Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871
https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.032
Abstract
About the Authors
V. V. OmelyanovskiyRussian Federation
MD, Dr Sci Med, Professor, General Director; Head of the Center for Healthcare Funding
Researcher ID: P-6911-2018; Scopus Author ID: 6507287753
10-5 Khokhlovsky per., Moscow 109028, Russia
3-2 Nastasyinsky per., Moscow 127006, Russia
E. A. Maksimkina
Russian Federation
MD, Dr Sci (Pharmaceutical Sciences), Professor, Director
3 Rakhmanovskiy per., Moscow 127994, Russia
8-2 Trubetskaya Str., Moscow 119048, Russia
O. I. Ivakhnenko
Russian Federation
Deputy Head of the Department of Methodological Support of Comprehensive HTA; Researcher of the Center for Healthcare Funding
Researcher ID: X-4590-2019; Scopus Author ID: 57208723430
10-5 Khokhlovsky per., Moscow 109028, Russia
3-2 Nastasyinsky per., Moscow 127006, Russia
M. V. Avxentyeva
Russian Federation
MD, Dr Sci Med, Advisor to the Director-General; Leading Research Fellow at the Center of Health Care Finance; Professor at the High School of Health Administration
10-5 Khokhlovsky per., Moscow 109028, Russia
3-2 Nastasyinsky per., Moscow 127006, Russia
8-2 Trubetskaya Str., Moscow 119048, Russia
M. V. Sura
Russian Federation
MD, PhD, Head of the Scientific and Research Department; Leading Researcher at the Center for HTA, Institute for Applied Economic Research
10-5 Khokhlovsky per., Moscow 109028, Russia
82 Vernadskogo pr., Moscow 119571, Russia
G. R. Khachatryan
Russian Federation
Head of the Department of Methodological Support of Comprehensive Health Technology Assessment; Junior Researcher at the Center for Healthcare Funding; Researcher, Laboratory for Technology Assessment in Health Care, Institute of Applied Economic Research
10-5 Khokhlovsky per., Moscow 109028, Russia
3-2 Nastasyinsky per., Moscow 127006, Russia
82 Vernadskogo pr., Moscow 119571, Russia
References
1. Sura M. V., Omelyanovskiy V. V. Evolution of the expertise system for the development of Vital and Essential Drug List. Medical Technologies. Assessment and Choice. 2011; (3): 30–33. (In Russ.)
2. Omelyanovskiy V.V., Sura M.V., Avxentyeva M.V., Khachatryan G.R. The Rules for Creation of Federal Drug Lists: Current State and Development Prospects. Medical Technologies. Assessment and Choice. 2018; (3): 9–17. (In Russ.) DOI: https://doi.org/10.31556/2219-0678.2018.33.3.009-017.
3. Khachatryan G. R., Ivakhnenko О. I., Sura M. V., Avxentyeva М. V. Assessment of the Methodological Quality of Economic Evaluations: Main Mistakes. Medical Technologies. Assessment and Choice. 2019; (1): 8–17. (In Russ.) DOI: https://doi.org/10.31556/2219-0678.2019.35.1.008-017.
4. Ivakhnenko O.I., Khachatryan G.R., Sura M.V., Avxentyeva M.V., Omelyanovskiy V. V. Results of Methodological Quality Assessment of Budget Impact Analysis: Main Mistakes. Medical Technologies. Assessment and Choice. 2018; (4): 11–18. (In Russ.) DOI: https://doi.org/10.31556/2219-0678.2018.34.4.011-018.
Review
For citations:
Omelyanovskiy V.V., Maksimkina E.A., Ivakhnenko O.I., Avxentyeva M.V., Sura M.V., Khachatryan G.R. Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871. FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology. 2020;13(2):113-123. (In Russ.) https://doi.org/10.17749/2070-4909/farmakoekonomika.2020.032

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.